![Kenneth Stauderman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Stauderman
Fondateur chez
CALCIMEDICA, INC.
Fortune : 10 575 $ au 31/05/2026
Profil
Kenneth A. Stauderman is the founder of CalciMedica Subsidiary, Inc., founded in 2006, where the title held is Chief Scientific Officer.
Dr. Stauderman is the founder of CalciMedica, Inc., founded in 2007, where the title held is Chief Scientific Officer.
Former jobs include Director-Olecular & Cell Biology at Sibia Neurosciences, Inc. from 1994 to 2000; Executive Director-Biology & Lead Discovery at TorreyPines Therapeutics, Inc. from 2000 to 2007; Senior Scientist at Sanofi-Aventis U.S.
LLC from 1986 to 1994; and Senior Scientist at Marion Merrell Dow Pharmaceutical, Inc. Education includes undergraduate studies at the University of Virginia and a doctorate from Texas University of Health Center at San Antonio.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CALCIMEDICA, INC. 0,08 % | 28/07/2025 | 12 944 ( 0,08 % ) | 10 575 $ | 31/05/2026 |
Postes actifs de Kenneth Stauderman
| Sociétés | Poste | Début |
|---|---|---|
| CALCIMEDICA, INC. | Fondateur | 01/01/2007 |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Fondateur | 11/08/2009 |
Anciens postes connus de Kenneth Stauderman
| Sociétés | Poste | Fin |
|---|---|---|
TorreyPines Therapeutics, Inc.
 TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Corporate Officer/Principal | 01/01/2007 |
Sibia Neurosciences, Inc.
 Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Corporate Officer/Principal | 01/01/2000 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Directeur Technique/Scientifique/R&D | 01/01/1994 |
Marion Merrell Dow Pharmaceutical, Inc. | Directeur Technique/Scientifique/R&D | - |
Formation de Kenneth Stauderman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Sibia Neurosciences, Inc.
Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Health Technology |
CalciMedica Subsidiary, Inc.
CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Texas University of Health Center at San Antonio
 Texas University of Health Center at San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marion Merrell Dow Pharmaceutical, Inc. | |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
